UiPath Sees Unusually Large Options Volume (NYSE:PATH)

Key Points

• UiPath experienced a significant increase in call options trading volume, with 66,008 call options purchased, marking a 44% rise compared to the average volume.
• Insider trading activity revealed that CEO Daniel Dines and insider Brad Brubaker sold substantial amounts of company stock, indicating a combined decrease in their ownership of approximately 4.14%.
• Stock analysts have mixed ratings for UiPath, with a consensus rating of "Hold" and target prices ranging from $12.50 to $16.00, reflecting varying levels of confidence in the company's future performance.

UiPath, Inc. (NYSE:PATH - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Traders bought 66,008 call options on the company. This is an increase of 44% compared to the average volume of 45,923 call options.

Insider Buying and Selling

In related news, insider Brad Brubaker sold 27,580 shares of the business's stock in a transaction on Wednesday, October 15th. The shares were sold at an average price of $16.68, for a total value of $460,034.40. Following the completion of the sale, the insider directly owned 662,939 shares of the company's stock, valued at $11,057,822.52. The trade was a 3.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of the firm's stock in a transaction that occurred on Wednesday, October 22nd. The stock was sold at an average price of $15.53, for a total transaction of $698,850.00. Following the transaction, the chief executive officer owned 29,738,585 shares in the company, valued at approximately $461,840,225.05. This trade represents a 0.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,193,990 shares of company stock worth $31,558,381 in the last ninety days. 23.19% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UiPath

A number of institutional investors have recently modified their holdings of the stock. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of UiPath in the 2nd quarter valued at $28,000. AdvisorNet Financial Inc lifted its stake in shares of UiPath by 320.4% in the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock valued at $32,000 after purchasing an additional 1,887 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of UiPath by 48.0% in the 2nd quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock valued at $38,000 after purchasing an additional 969 shares during the last quarter. IFP Advisors Inc lifted its stake in shares of UiPath by 508.0% in the 2nd quarter. IFP Advisors Inc now owns 3,283 shares of the company's stock valued at $42,000 after purchasing an additional 2,743 shares during the last quarter. Finally, Brooklyn Investment Group boosted its stake in shares of UiPath by 314.3% during the 1st quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock worth $46,000 after acquiring an additional 3,420 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on PATH shares. Canaccord Genuity Group dropped their price objective on shares of UiPath from $16.00 to $15.00 and set a "buy" rating on the stock in a research note on Monday, September 8th. BMO Capital Markets raised their target price on UiPath from $12.50 to $13.00 and gave the company a "market perform" rating in a report on Thursday, October 2nd. Cowen reaffirmed a "hold" rating on shares of UiPath in a research note on Friday, September 5th. Wall Street Zen raised UiPath from a "buy" rating to a "strong-buy" rating in a research note on Saturday, September 6th. Finally, Zacks Research raised shares of UiPath from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat, UiPath currently has a consensus rating of "Hold" and a consensus target price of $13.21.

UiPath Trading Down 7.8%

PATH stock traded down $1.27 during trading on Wednesday, reaching $15.02. The stock had a trading volume of 27,800,191 shares, compared to its average volume of 35,834,896. UiPath has a 1-year low of $9.38 and a 1-year high of $18.74. The company has a market capitalization of $7.97 billion, a P/E ratio of 500.50, a PEG ratio of 6.02 and a beta of 1.07. The firm has a fifty day moving average price of $12.75 and a 200 day moving average price of $12.31.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.08 by $0.07. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The company had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. During the same quarter last year, the business earned $0.04 earnings per share. UiPath's revenue was up 14.6% compared to the same quarter last year. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Sell-side analysts predict that UiPath will post -0.17 EPS for the current year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.